Vita Pure CBD is composed of natural crystalline cannabidiol with a 99% of purity. It is prized for its anti-inflammatory and antioxidant properties and is derived from the leaves of industrial hemp. It stands out for its anti-inflammatory and moisturization effect, but also for helping enhance the skin barrier. Its anti-inflammatory properties allow it to calm acne-prone skin, reducing redness and therefore creating a more homogeneous tone. Vita Pure CBD can be used in soothing, moisturizing, acne control, anti-hair loss, hair growth, anti-dandruff, and anti-inflammatory products.
| Name (CAS Number) | |
|---|---|
| Cannabidiol (13956-29-1) | Sign in to view |
The following lists represent a selection of UL's LOLI Regulatory Database, curated for Prospector in Compliance Highlights. Need more context for understanding these highlights? We recommend UL's Navigator, your gateway to regulatory compliance (free trial available).
| Name (CAS Number) | |
|---|---|
|
Cannabidiol (13956-29-1)
|
Sign in to view |
Quimvita was founded in 1964 producing mineral salts, a business that gradually diversified until it landed in the development and production of specialty ingredients for the production of cosmetics and food products.
In cosmetics, they seek to respond to the challenges faced by formulators as a result of legislative changes and new consumer demands by developing clean beauty ingredients.
And if you think that Quimivita will only offer you its ingredients, you don't know them at all!
They'll take the headache out of achieving ingredient compatibility with the help of their applications laboratory, which will give you the support you need to achieve the formula you have in mind.
In the food sector, they offer you a variety of formulas adapted to different audiences.
So whether you are looking to develop a product for athletes, for the elderly, to improve intestinal health, or even to improve the organoleptic quality of your products, they are your partner.
La información presentada aquí fue adquirida por UL desde el productor del material. UL hace un esfuerzo considerable para asegurar la exactitud de estos datos. Sin embargo, UL no asume responsabilidad por los valores de los datos y alienta firmemente a que tras la selección final del material, los puntos de los datos sean validados con el proveedor de la materia
QUIMIVITA PRODUCTS SL hacer su documentación disponible en las siguiente/s región/es
Es usted un distribuidor que esta interesado en aparecer listado aquí? Por favor contáctenos!
The following lists represent a selection of UL's LOLI Regulatory Database, curated for Prospector in Compliance Highlights. Need more context for understanding these highlights? We recommend UL's Navigator, your gateway to regulatory compliance (free trial available).
With a Premium Prospector account, view regulatory advisory and retailer compliance on an ingredients level for your material searches. The full set of lists reviewed have been curated by UL's LOLI Regulatory Database specific for Prospector. Upgrade today!
Lists combine the ease of Bookmarks with the versatility of Tags. Instead of one collection of bookmarked items, create as many collections, called "Lists," as you need.
Find the link to your List page in the user menu.
All Tags have been converted to separate Lists, and your bookmarked items have been saved to a "Bookmarks" List.
When you click the Add to List button, a dropdown of your existing Lists appears. Click the List name to which you want to add this product or formula.
You can also create a new List. Simply click "Create a New List" and enter a name.
When you define a new List, the current item is automatically added to it. You can add a product or formula to as many Lists as you need.
Easily see which Lists this item appears in, and quickly go to that List from the links that appear on the page.
Lo sentimos pero la industria que ha escogido no esta disponible en el idioma seleccionado en este momentos. Usted puede seleccionar un idioma a continuación para avanzar en esta industria o cerrar este dialogo.
GDPR Notice: